podcast

Views & Analysis

Lung cancer’s patient information gap: the pharmaphorum podc...

For episode 13 of the pharmaphorum podcast podcast I went to AstraZeneca’s London base to meet Paul Naish, who’s the company’s director of oncology advocacy and government affairs, to talk

R&D

Chris Molloy from the Medicines Discovery Catapult on the pharmaphorum podcast

The state of UK drug discovery: the pharmaphorum podcast

The UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role of complex cell models were all on the agenda for episode 12 of the

R&D

pharmaphorum podcast with IAVI on global health challenges

Addressing global health challenges: the pharmaphorum podcas...

For episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to record a special roundtable episode in Philadel

Market Access

pharmaphorum podcast bluebird bio Nicola Redfern

Gene therapy and market access: the pharmaphorum podcast

For episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK.

R&D

pharmaphorum podcast Matoke Pharma Alan Westwood

AMR research and Matoke Pharma: the pharmaphorum podcast

Re-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s plans to target antimicrobial resistance (AM

Digital

GSK and digital disruption: the pharmaphorum podcast

Digital innovation and disruption in healthcare are the subject of this episode of the pharmaphorum podcast, for which I visited GlaxoSmithKline at their Stockley Park base to speak with Ka